Abstract
Background Laparoscopic Sleeve Gastrectomy has become one of the most popular bariatric surgery types and helps treating not only obesity but also endocrinological diseases related to obesity. Therefore we aimed to evaluate the effects of laparoscopic sleeve gastrectomy on the treatment of type 2 diabetes.MethodsAll patients, who underwent morbid obesity surgery during 2013–2014 and had a HbA1c >6 % were included in this prospective study. Demographical data, usage of oral antidiabetic drugs or insulin were recorded, and laboratory findings as HbA1c and fasting plasma glucose were evaluated preoperatively and postoperatively at the 6th and 12th months. Diabetes remission criteria were used to assess success of the surgical treatment.ResultsTotally 88 patients were included in this study. 55 patients were using oral antidiabetic drugs and 33 patients were using insulin. At the 6th month complete remission was observed in 80 (90.9 %), partial remission in 3 (3.4 %) and persistent diabetes in 5 (5.6 %) patients. At the 12th month complete remission was observed in 84 (95.4 %), partial remission in 1 (1.1 %) and persistent diabetes in 3 (3.4 %) patients.ConclusionsThis study indicated that laparoscopic sleeve gastrectomy surgery achieved a complete remission of diabetes in 95.4 % patients having type 2 diabetes during a 1 year fallow up period. However, complete remission of type 2 diabetes has been reported as 80 % during long term fallow up in the literature. In our opinion this rate may change with longer follow up periods and studies involving more patients suffering type 2 diabetes.
Highlights
Laparoscopic Sleeve Gastrectomy has become one of the most popular bariatric surgery types and helps treating obesity and endocrinological diseases related to obesity
Bariatric surgery varies from minimal surgical interventions as laparoscopic gastric plication and laparoscopic sleeve gastrectomy (LSG) to major surgical interventions as laparoscopic Roux-en-Y Gastric By-pass (RYGBP), laparoscopic mini gastric bypass and duodenal switch procedures
Totally 89 patients with type 2 diabetes, who underwent LSG in our clinic during the years 2013–2014 were eligible for this study
Summary
Laparoscopic Sleeve Gastrectomy has become one of the most popular bariatric surgery types and helps treating obesity and endocrinological diseases related to obesity. We aimed to evaluate the effects of laparoscopic sleeve gastrectomy on the treatment of type 2 diabetes. Type 2 diabetes is commonly a component of metabolic disorders in the morbid obese patient (http://www.who.int/gho/ncd/risk_factors/ obesity_text/en/). It is estimated, that 35.8 million (2.3 %) people in the world are diagnosed to have overweight or obesity This serious health issue deserves to attract attention by internal specialists, and by surgeons. Bariatric surgery may fill the gap between medical treatment and complete remission in type 2 diabetes. Achieves good long-term results including weight-loss maintenance, reduction of Mihmanli et al SpringerPlus (2016) 5:497 comorbidities and improvement of quality of life (Cho et al 2015)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
